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easily accommodate a side-by-side dimer, but the pro-Steven Henikoff* and Danielle Vermaak
Howard Hughes Medical Institute truding NH2 group of guanidine represents a major steric
obstacle for pyrrole rings bound in the minor groove.Fred Hutchinson Cancer Research Center
1100 Fairview Avenue North Replacement of C-H in pyrrole with N: in imidazole
allows for the formation of a hydrogen bond with thisSeattle, Washington 98109
guanidine NH2. In the context of a side-by-side dimer, a
G/C base pair is contacted by an imidazole (Im) touching
guanine and a pyrrole (Py) touching cytosine. For exam-
Sometimes science fact resembles science fantasy,
ple, GTA/CAT can be recognized by ImPyPy/PyPyPy.
more suitable for the supermarket checkout display than
Extending beyond a few base pairs requires spacers,
the research library. A case in point is an article in the
because the polyamides become strained when follow-
November issue of Molecular Cell that could pass for
ing the DNA trajectory. A b-alanine (b) is generally used
the subject of a B-grade sci-fi movie: Some unfortunate
as a spacer, because a b can take the place of a pyrrole,
creature ingests a compound cooked up in the labora-
allowing recognition of longer sequences. To obtain di-
tory and undergoes a profound transformation. Implau-
meric compounds with increased specificity and affinity,
sible as such a scenario may seem, Laemmli’s group
a linker connects the two side-by-side monomers to
reports that when certain Drosophila larvae are fed a
form a hairpin.
sequence-specific DNA binding compound they un-
The subnanomolar affinities for specific short se-
dergo homeotic transformations (Janssen et al., 2000a).
quences achieved in these studies encouraged in vivo
These transformations involve targeting of the com-
experiments. Transcription factor binding sites provide
pound to the minor groove of a GAGAA-rich repetitive
attractive targets in cases where minor-groove binding
element, and evidently mimic a mutation in the gene
would interfere with function. For example, TFIIIA has 9
encoding the GAGA factor (GAF) DNA binding regulatory
zinc fingers, some of which contact the minor groove.
protein. This astonishing result not only has implications
for understanding repetitive sequences, heterochroma-
tin, and DNA binding interactions, but also provides a
new class of cytological tools. What’s more, the strange
fate of bugs on drugs represents another milestone on
the way to therapeutic drugs that bind DNA in the minor
groove.
Minor-Groove Binding Compounds
This breakthrough by Laemmli’s group builds upon ex-
tensive studies of synthetic compounds that are mod-
eled on the naturally occurring drugs distamycin and
netropsin. These are polyamides containing aromatic
pyrrole rings, which fit snugly into the narrow minor
groove of A/T-rich DNA (Figure 1, top). Over the past
decade, a series of reports, principally from the Dervan
laboratory, have succeeded in increasing the sequence
specificity and range of minor-groove binding com-
pounds, while still maintaining binding affinities in the
nanomolar range (reviewed by Wemmer, 2000). Because
polyamide subunits are connected by peptide-like am-
ide bonds, they can be synthesized using modified pro-
tocols for conventional solid state peptide synthesis.
The success of a polyamide derivative in targeting a
given sequence can be assessed by standard foot-
printing assays, and structures can be determined from
NMR spectra of polyamide compounds bound to dou-
ble-stranded oligonucleotides.
A DNA duplex that consists of only A/T base pairs
has a narrow minor groove that can accommodate a
single molecule of distamycin (Figure 1). However, dista-
Figure 1. Minor Groove Binding Dyes
mycin also binds as a side-by-side dimer that widens
Structure of distamycin (top), which targets AT-rich DNA, and P31
the groove of A/T DNA. Sequences containing G/C base (bottom), which targets GAGAAGAGAA. 3D structural representa-
pairs have a wider minor groove and can therefore more tions show binding of a single molecule of distamycin (yellow) in
the narrow minor groove (left), and binding of two side-by-side mole-
cules (right), which widen the groove. Subunits of distamycin and
P31 are color-coded: pyrroles are blue, imidazoles are red, and* To whom correspondence should be addressed (e-mail: steveh@
fhcrc.org). b-alanines are green.
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A polyamide compound targeted to a minor-groove con- tion that others have used to target mixed AT and GC
duplexes. It will be interesting to determine the structuretact site, AGTACT, interfered with targets of TFIIIA tran-
scription in Xenopus kidney cells (Gottesfeld et al., of the P31-DNA complex, and whether this Watson-
strand-only code applies generally to the design of mi-1997), and in subsequent studies, other compounds
successfully targeted different transcription binding nor-groove binders of homopurine/homopyrimidine du-
plexes.sites and interfered with in vivo binding. These experi-
ments showed that polyamides are taken up by cells, These dyes were used to stain squashed preparations
of chromosomes (Janssen et al., 2000b). Two oligopyr-and can gain access to their cognate sites at concentra-
tions sufficient for interference with transcription to be roles, P9F and Lex9F, showed similar targeting of known
AT-rich regions in both cell line and polytene nuclei. Indetected. No general toxic effects were found, raising
the hope that these compounds can eventually be used Drosophila, AT-rich satellites can either be complex,
with several AT-rich motifs, or simple, consisting primar-as drugs.
AT Hooks ily of the pentamer AATAT, and both types were stained
by the dyes. In addition to these satellites, which areSome natural peptides also bind in the minor groove. For
instance, certain variant histones have tails that contain located in the pericentric heterochromatin, numerous
euchromatic sites were stained. The banded pattern“SPKK” or similar motifs, which protect the minor groove
in footprinting studies (Churchill and Suzuki, 1989). Per- seen in polytene chromosomes does not correspond
exclusively to classical band or interband regions, andhaps the most widespread of these minor-groove bind-
ing peptides was termed an “AT hook” by Reeves, who perhaps reflects the distribution of SARs in the Drosoph-
ila genome. Banding patterns seen on polytene chromo-determined that HMG-I(Y) binding to DNA is mediated
by a set of three similar 11-12mers that footprinted A/T- somes are extraordinarily detailed, and should be useful
in general for assessing the genome-wide sequencerich binding sites and could be competed using a minor-
groove binding compound (Reeves and Nissen, 1990). specificity of minor-groove binding compounds.
The most impressive evidence for specificity cameSince then AT hooks have been found in numerous chro-
matin-associated proteins (Aravind and Landsman, from utilizing a fly mutation, brownDominant (bwD), which is
an insertion of z1–2 Mb of GAGAA into the distally lo-1998). AT hooks consist of an invariant GRP core motif
surrounded by mostly basic residues. In cases of pro- cated brown gene. In polytene chromosomes, satellite
repeats undergo little if any polytenization, and theteins with single AT hooks, minor-groove peptide bind-
ing is thought to play an auxiliary role in increasing the GAGAA pericentric repeats are undetectable. However,
bwD is sandwiched between distal euchromatic se-specificity of a DNA binding protein.
A few proteins have a large number of AT hooks, quences, and undergoes substantial polytenization
(Platero et al., 1998). Thus, essentially all of the GAGAAallowing for binding to AT-rich repeats, such as AT-rich
satellites, which are abundant in Drosophila heterochro- repeats detectable in polytene chromosomes from bwD
mutants are at this single locus, providing an idealmatin. In fact, the first example of an AT-rich DNA bind-
ing protein was described 20 years ago: the Drosophila whole-genome assay for the targeting specificity. In-
deed, the GAGAA-specific drug P31 targeted bwD exclu-D1 chromosomal protein specifically binds to AT-rich
satellite repeats (Rodriguez Alfageme et al., 1980). Upon sively.
Thus, two completely different minor-groove bindingsequencing, D1 was found to contain 11 AT hooks. An
artificial protein that contains 20 HMG-I AT hooks, dye conjugates, P9F and P31T, target their substrates
in cytological preparations with high specificity, provid-MATH-20, resembles D1 in also binding to AT-rich Dro-
sophila DNA, including scaffold-associated regions (SARs) ing a compelling case for the general utility of minor-
groove binding dye conjugates. Compounds with differ-and satellites (Strick and Laemmli, 1995). The binding
of D1 and MATH-20 to naturally occurring satellites em- ent specificities can reveal different landmarks, which
together with multiple fluorochromes that emit at differ-phasizes the potential of satellites as targets for de-
signer peptide compounds. ent wavelengths (e.g., Sachs et al., 2000), will provide
researchers with a new class of versatile cytologicalMinor-Groove Binding Dyes as Cytological Tools
Laemmli’s team realized that by conjugating minor- tools.
What Happens to Flies on Drugs?groove binding compounds with dyes, Drosophila chro-
mosomes can reveal sequence specificity in situ on a At first glance, the specific targeting of minor-groove
binding compounds to satellites would seem unlikelyglobal scale. Compounds targeted specifically to SARs
and to two pentameric satellite repeats were synthe- to have functional consequence in vivo, as satellites
comprise the most inert subset of gene-poor constitu-sized, tested by footprinting, and converted to dyes by
addition of a fluorescent group (Janssen et al., 2000b tive heterochromatin. However, inertness can itself pro-
vide a functional assay, because reporter genes juxta-[November issue of Molecular Cell]). Addition of the fluor
only slightly affected the affinity and specificity of pyr- posed to heterochromatin are silenced, a phenomenon
known as position-effect variegation (PEV; reviewed inrole-based AT-rich binders.
To target the GAGAA satellite, a polyamide compound Weiler and Wakimoto, 1995). PEV is an extremely sensi-
tive assay for detecting changes in reporter gene activ-was designed in which a monomeric minor-groove bind-
ing code was applied to the 10 base sequence GAGAA ity, providing a readout for alterations in either the state
of heterochromatin or the accessibility of the reporter.GAGAA, where Im binds G/C and Py or b binds A/T: Im-
b-Im-Py-b-Im-b-Im-b-(dimethylaminopropylamide) (Fig- Therefore, PEV can be used to assess the effect of
minor-groove binding drugs in vivo. Evidently, minor-ure 1, bottom). The authors provided evidence that this
compound (P31) binds in a 1:1 ratio in the minor groove, groove binding can affect PEV, because expression of
MATH-20 in flies causes PEV suppression (Girard et al.,rather than in the conventional side-by-side conforma-
Minireview
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Figure 2. Relocalization of GAF from Euchro-
matin to bwD
(A) Cycling of GAF from dispersed sites in
euchromatin to GA-rich satellites in pericen-
tric heterochromatin and to bwD, which is lo-
cated near the distal tip of chromosome arm
2R. (B) GAF is found at numerous sites
throughout euchromatin, but is undetectable
at bwD during interphase. After treatment with
P31, but not P9, GAF relocalizes to bwD in
polytene nuclei.
1998). Given that AT binding compounds show similar carrying two copies (bwD/bwD) died. Considering that
the brown gene is entirely dispensible, and bwD/bwD fliesspecificity to MATH-20, they would be expected to simi-
larly suppress PEV. However, this prediction presup- are healthy, this is a very odd result.
What Does P31 Do to bwD?poses that enough of a compound can be ingested, can
diffuse into the hemolymph, can be transported into Close examination of the P31-fed bwD survivors pro-
vided intriguing evidence for multiple homeotic transfor-target cells and can reach their DNA targets to have
a detectable effect. Impressively, this prediction was mations (Janssen et al., 2000a). Extra bristles revealed
a transformation of the sixth abdominal segment intofulfilled for larvae grown on food containing 100 mM
of the AT binder P9. Emerging adults displayed PEV the fifth, fewer sex combs revealed a Sex-combs-
reduced-like transformation, and larger halteres in com-suppression, i.e., derepression of the classical white-
mottled-4 (wm4) PEV mutation, showing no other ill ef- bination with an Ultrabithorax gain-of-function mutation
revealed enhanced transformation of the third thoracicfects (Janssen et al., 2000a).
The effect on PEV is almost certainly attributable to segment into the second. This unusual combination of
phenotypes had been seen before: partial loss-of-func-targeted minor-groove binding, because the effect was
no different from what was seen for MATH-20. However, tion mutations in the gene encoding GAF cause the
same syndrome (Farkas et al., 1994). So the questionboth the mechanism of PEV suppression and the identity
of in vivo targets of the drugs (and of MATH-20) are became, does P31 interact with bwD in such a way that
GAF levels are reduced?uncertain. It is possible that AT-rich sequences in the
local vicinity of the white reporter gene are targeted. An unexpected connection between bwD and GAF had
previously been reported (Platero et al., 1998). GAF ap-Alternatively, an AT-rich satellite located within the het-
erochromatin that induces PEV might be altered, al- pears to bind exclusively to GA-rich satellites, including
bwD, during mitosis (Figure 2A), but does not bind at allthough the closest AT-rich satellite to white is located
on the other side of the entire rDNA locus. As detailed during interphase. The absence of GAF from interphase
heterochromatin is seen most clearly in polytene chro-below, we favor a third interpretation, in which satel-
lites behave as sinks for heterochromatin binding pro- mosomes, where thousands of euchromatic sites have
GAF, yet the heterochromatic chromocenter and bwDteins. All of these models have in common the idea that
derepression results from opening chromatin by minor- are completely devoid of GAF (Figure 2B). Therefore,
the GA-rich satellites provide a potential binding reser-groove binding. We stress that uncertainties with re-
spect to mechanism should not detract from the impor- voir for GAF that fills up only at the onset of mitosis,
during which time the euchromatin condenses and losestance of this result, that a developmental change can
be caused by ingestion of a DNA binding compound all detectable GAF. These observations provide the con-
nection between bwD and GAF that can potentially ex-that is known to target specific DNA sequences.
The GAGAA binding compound, P31, had no effect plain the P31-bwD syndrome. Perhaps the binding of
P31 to bwD opens it up, resulting in the unscheduledon wm4, and some AT-rich binders also failed to show
an effect. However, this could be a trivial consequence transfer of GAF from euchromatic sites to bwD at in-
terphase, a process that normally occurs only duringof reduced uptake, transport, or in vivo target binding
affinity. A somewhat different PEV assay for testing mitosis.
A critical test of this scenario is to treat with P31 anddrugs was possible using bwD, which causes PEV-like
trans-inactivation of a somatically paired wild-type copy look for transfer of GAF from euchromatic sites to bwD
by staining of polytene chromosomes with anti-GAF an-of the brown gene. Although no effects on bwD were
seen with P9, ingestion of P31 may have led to modest tibody. Laemmli’s group performed this test, and the
result was stunning (Figure 2B). bwD normally shows noderepression of the brown gene. However, interpreta-
tion of this result was complicated by the surprising anti-GAF staining, whereas nearly all detectable GAF in
P31-treated nuclei was found at bwD. Concomitantly,response of bwD-bearing flies to P31: Wild-type flies
showed no ill effects from eating P31, but flies carrying anti-GAF staining of euchromatic bands was nearly
abolished (Janssen et al., 2000a). Thus, it appears thata single copy of bwD (bwD/1) were feeble, and most flies
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Platero, J.S., Csink, A.K., Quintanilla, A., and Henikoff, S. (1998). J.P31-induced opening of bwD provides a sink for GAF,
Cell Biol. 140, 1297–1306.which leaves its normal sites. Consistent with this inter-
Reeves, R., and Nissen, M.S. (1990). J. Biol. Chem. 265, 8573–8582.pretation, the authors note that P31 binding and GAF
Rodriguez Alfageme, C., Rudkin, G.T., and Cohen, L.H. (1980). Chro-binding to GAGAA repeats are not mutually exclusive.
mosoma 78, 1–31.Furthermore, normal GAF binding sites, which are typi-
Sachs, R.K., Hlatky, L.R., and Trask, B.J. (2000). Trends Genet. 16,cally GAGAG, are not targeted by P31, so that P31 is
143–146.expected to open up bwD preferentially to euchromatic
Strick, R., and Laemmli, U.K. (1995). Cell 83, 1137–1148.GAF binding sites. Unscheduled GAF binding to bwD
Weiler, K.S., and Wakimoto, B.T. (1995). Annu. Rev. Genet. 29,after P31 treatment provides compelling evidence for
577–605.
Laemmli’s model that minor-groove binding exerts its
Wemmer, D.E. (2000). Annu. Rev. Biophys. Biomol. Struct. 29,effect on chromatin by opening it up.
439–461.
GAF is not the only mitosis-specific satellite binding
protein. Drosophila Prod protein, which binds to the AT-
rich AATAAGATAC decameric satellite, shows similar
cycling behavior (Platero et al., 1998), and reservoirs
for other proteins might exist in heterochromatin. We
wonder if titration by a drug-opened satellite sink had
occurred for the AT binders, resulting in PEV suppres-
sion. AT-rich satellites are especially abundant in the
Drosophila genome, and so it seems reasonable to sus-
pect that if these satellites open up, they would become
massive sinks for proteins needed for heterochromatic
silencing. Thus, titration of silencing factors by satellites
could have led to derepression of the white reporter
gene in wm4. This explanation may have precedent in
the well-known PEV suppressing effect of extra Y chro-
mosomes, which are thought to derepress wm4 and other
PEV mutations by titrating out heterochromatin-specific
factors, reducing their availability at sites subject to PEV
(Dimitri and Pisano, 1989).
The human genome also has satellites in abundance.
Indeed, the Ikaros regulatory protein binds to human
gamma satellites, which have been proposed to function
as Ikaros storage sites in lymphocytes (Cobb et al.,
2000). It might not be too far-fetched to imagine that
human satellite sinks will someday provide therapeutic
drug targets. When converted to dye-conjugated com-
pounds, minor-groove binders have an added advan-
tage, as demonstrated by Laemmli’s group, in that they
illuminate the DNA target that they open up. Potentially,
a therapeutic drug can reveal its DNA target, analogous
to illumination of proteins linked to GFP in living organ-
isms. Perhaps future decongestants will not only clear
your nose, but also light it up!
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